French-based biotechnology company Novasep has installed and validated a new industrial HPAIâ€¨ (highly potent active ingredient) manufacturing plant in its facility at Le Mans, France.
The move follows the establishment of a second kilo-lab for highly potent substance synthesis andâ€¨ purification.
In a press release, the company said the â€¨â‚¬8m investment had been made to meet growing demand forâ€¨ multipurpose chemistry and purification of highly potent molecules in a highly confined current Good Manufacturing Practices environment.
The firm said the value of combined investments at the Le Mans site was now â‚¬50m.
Novasep provides synthesis support services for highly potent molecules, from early stage phases of development through to commercial â€¨quantities.